Neurogene Competitors and Similar CompaniesClear all

Neurogene's competitors and similar companies include Dyne Therapeutics and Ambrx.

	Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.	Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.	Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
Founding Date	Founding Date 2018	Founding Date 2018	Founding Date 2003
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare Technology biotech genetics medtech pharma therapy	Tags Healthcare Technology biotech genetics pharma therapy	Tags Healthcare biotech genetics pharma therapy
Locations	Locations New York, US HQ Houston, US	Locations Waltham, US HQ	Locations San Diego, US HQ
Employees	Employees 1091% decrease	Employees 1451% decrease	Employees 70
Valuation ($)	Valuation ($) N/A	Valuation ($) 3.1 b	Valuation ($) 1.8 b
Financial
Net income	Net income N/A	Net income ($446.2m) (FY, 2025)	Net income ($78m) (FY, 2022)
Funding
Total funding raised	Total funding raised $ 68.5m	Total funding raised $ 165m	Total funding raised $ 347.9m